News

Biosimilar matches up well against infliximab in RA trial

Publish date: September 10, 2013

 

FROM ANNALS OF THE RHEUMATIC DISEASES

jevans@frontlinemedcom.com

Pages

Recommended Reading

Puffy fingers improves predictiveness of very early systemic sclerosis diagnosis
MDedge Internal Medicine
Meta-analysis: Lateral wedges don’t reduce medial knee OA pain
MDedge Internal Medicine
Switching nonadherent to denosumab improved bone density
MDedge Internal Medicine
Anserine bursitis: Often-overlooked cause of knee pain
MDedge Internal Medicine
Suboptimal, dissatisfying treatment affects many psoriasis patients
MDedge Internal Medicine
Omega-3 fatty acid found in fish may reduce RA risk
MDedge Internal Medicine
Current diagnostic criteria for early rheumatoid arthritis must be used judiciously
MDedge Internal Medicine
Perceived stigma linked to depression in female SLE patients
MDedge Internal Medicine
Depression in pediatric SLE matches average rates
MDedge Internal Medicine
Sleep problems common, untreated in systemic lupus erythematosus
MDedge Internal Medicine